Metoprolol and Verapamil Interaction: Is It Safe?

Metoprolol (Lopressor, Toprol-XL) and verapamil (Calan, Verelan, Isoptin) are both used to treat heart conditions including high blood pressure, angina, and certain arrhythmias. However, combining a beta-blocker like metoprolol with a non-dihydropyridine calcium channel blocker like verapamil is considered a classically dangerous drug interaction in cardiology. Both drugs independently slow heart rate and electrical conduction through the heart's AV node — and combining them can cause life-threatening bradycardia, heart block, and cardiac arrest.

What Happens When You Combine Them

The heart's rate and rhythm are controlled in part by two intersecting mechanisms: the sympathetic nervous system (which speeds the heart up) and calcium-dependent channels in the sinoatrial (SA) and atrioventricular (AV) nodes. Metoprolol is a selective beta-1 adrenergic blocker that opposes sympathetic stimulation, slowing the heart rate and reducing the speed at which electrical impulses travel through the AV node. This is the intended effect when treating tachycardia or angina.

Verapamil is a phenylalkylamine calcium channel blocker — specifically one of the "non-dihydropyridine" class — which blocks L-type calcium channels directly in the SA and AV nodes. This also slows the heart rate and AV conduction, independent of the sympathetic nervous system.

When both drugs are present simultaneously, they suppress cardiac conduction through two distinct but convergent mechanisms. The combined effect on the AV node can be dramatic: the heart rate may fall severely (bradycardia below 40 beats per minute), and the AV node may fail to conduct impulses at all — a condition called complete heart block, where the ventricles stop contracting effectively. This can progress to cardiac arrest. Additionally, verapamil inhibits CYP3A4, which metabolizes metoprolol, raising metoprolol blood levels and compounding the pharmacodynamic interaction with a pharmacokinetic one.

Symptoms to Watch For

• Very slow pulse (below 50 beats per minute) — check by feeling your wrist or neck pulse
• Lightheadedness, dizziness, or feeling faint
• Fainting or loss of consciousness
• Severe fatigue or profound weakness
• Shortness of breath or chest discomfort
• Palpitations or feeling that the heart is skipping or pausing
• Cold, pale, or sweaty skin with no clear cause

Who Is Most at Risk

• Anyone receiving IV verapamil — intravenous verapamil combined with any beta-blocker carries immediate risk of cardiac arrest and is absolutely contraindicated
• Patients with pre-existing conduction disorders — sick sinus syndrome, existing AV block, or bundle branch block
• Elderly patients — age-related conduction system changes increase vulnerability
• Patients with heart failure — both drugs reduce cardiac contractility; combining them can precipitate acute decompensation
• Patients on other bradycardic drugs — digoxin, amiodarone, or other antiarrhythmics add additional conduction depression

What to Do

If you are prescribed both: This combination should prompt an immediate discussion with your cardiologist. In most cases, there is a safer alternative — typically using one drug or the other, or substituting a dihydropyridine calcium channel blocker (like amlodipine) for verapamil if both a beta-blocker and a calcium channel blocker are needed for blood pressure control.

Do not stop either medication abruptly: Abruptly stopping a beta-blocker can cause rebound tachycardia and is particularly dangerous in patients with coronary artery disease. Any changes to heart medications must be made under direct prescriber supervision with a careful tapering plan.

If symptoms occur: A very slow pulse, fainting, or severe lightheadedness while on either medication is an emergency. Call 911. Do not attempt to drive or take additional medications without medical guidance.

Frequently Asked Questions